Evidence map›Paper›PMID 31076350›Full record

ArticleMolecular metabolism2019

A spontaneous leptin receptor point mutation causes obesity and differentially affects leptin signaling in hypothalamic nuclei resulting in metabolic dysfunctions distinct from db/db mice.

Federica Piattini, Christelle Le Foll, Jan Kisielow, Esther Rosenwald, Peter Nielsen, Thomas Lutz, Christoph Schneider, Manfred Kopf

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Comprehensive mutations analyses ofFrontiers in nutrition · 2022
    Article
  8. Metabolic Syndrome: Lessons from Rodent andBioMed research international · 2022
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Federica PiattiniInstitute of Molecular Biomedicine, Department Biology, ETH Zürich, Switzerland.
Christelle Le FollInstitute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Switzerland.
Jan KisielowInstitute of Molecular Biomedicine, Department Biology, ETH Zürich, Switzerland.
Esther RosenwaldInstitute of Molecular Biomedicine, Department Biology, ETH Zürich, Switzerland.
Peter NielsenInstitute of Molecular Biomedicine, Department Biology, ETH Zürich, Switzerland.
Thomas LutzInstitute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Switzerland.
Christoph SchneiderInstitute of Molecular Biomedicine, Department Biology, ETH Zürich, Switzerland.
Manfred KopfInstitute of Molecular Biomedicine, Department Biology, ETH Zürich, Switzerland. Electronic address: Manfred.Kopf@ethz.ch.
ETH Zurich · CHInstitute for Biomedical Engineering · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveLeptin (Lep) plays a crucial role in controlling food intake and energy expenditure. Defective Lep/LepRb-signaling leads to fat accumulation, massive obesity, and the development of diabetes. We serendipitously noticed spontaneous development of obesity similar to LepR-deficient (db/db) mice in offspring from a C57BL/6J breeding and transmittance of the phenotype in a Mendelian manner. Candidate gene sequencing revealed a spontaneous point mutation in the LepRb gene. We investigated leptin responsiveness, leptin receptor signaling and metabolic phenotype of this novel LepRb mutant mouse variant.

methodsOverexpression and functional tests of the mutant LepRb in 3T3 cells. Measurement of leptin responsiveness in hypothalamic nuclei, glucose tolerance, food uptake and energy expenditure in the mutant mice.

resultsThe mutation results in the exchange of a glycine for serine (G506S) and introduces an alternative splice acceptor which, when used, encodes for a protein with a 40aa deletion that is retained in the cytoplasm. LepRb signaling was abrogated in the hypothalamic ventromedial nucleus (VMN) and dorsomedial nucleus (DMN), but only partially reduced in the hypothalamic arcuate nucleus (ARC) of LepRb

conclusionsThis study provides further insight into differences of the leptin responsiveness in VMN, DMN, and ARC and its metabolic consequences.

Indexed as

Point MutationAnimalsArcuate Nucleus of HypothalamusEnergy MetabolismFemaleGenetic Predisposition to DiseaseGlucoseHypothalamusLeptinMaleMiceMice, Inbred C57BLNeuronsObesityReceptors, LeptinSignal TransductionGlucoseLeptinleptin receptor, mouseReceptors, LeptinArcuate nucleusDorsomedial nucleusEnergy expenditureGlucose toleranceLeptin receptor mutationVentromedial nucleus

Identifiers

PMID31076350
PMCPMC6601129
OpenAlexW2941905771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.